Convalescent serum lines up as first-choice treatment for coronavirus

Convalescent serum lines up as first-choice treatment for coronavirus

Published in Nature Biotechnology:

Antibodies from blood donated by people who recovered from the illness and hyper-immunoglobulins are becoming treatments of choice for COVID-19, with recombinant polyclonal antibody approaches to follow.


Share Tweet Send
0 Comments
Loading...
You've successfully subscribed to COVID-19
Great! Next, complete checkout for full access to COVID-19
Welcome back! You've successfully signed in
Success! Your account is fully activated, you now have access to all content.